SHAREHOLDERS' EQUITY (DEFICIT)

12 Months Ended

Dec. 31, 2012

Stockholders' Equity Note [Abstract]

SHAREHOLDERS' EQUITY (DEFICIT)

8      SHAREHOLDERS’ EQUITY (DEFICIT)

No dividends were declared or paid by the Company during the years ended December 31, 2012 and 2011.

On January 21, 2012, the Company effected a one-for-300 reverse stock split. All share and per share numbers have been restated to reflect the reverse split.

On March 2, 2011, the Company issued 16,667 shares of common stock for the conversion of $50,000 of principal of the 10% Subordinated Convertible Notes Payable.

On July 6, 2011, the Company issued 30,000 shares of common stock for the conversion of $90,000 of principal of the 10% Subordinated Convertible Notes Payable.

On September 20, 2011, the Company issued 23,333 shares of common stock for the conversion of $70,000 of principal of the 10% Subordinated Convertible Notes Payable.

On September 14, 2011, the Company issued 5,000 shares of common stock for consulting services.  The stock was valued at $42 per share based on the market price of the stock on the date the agreement was made to issue the stock.  The Company recognized stock-based compensation expense of $210,000 as a result of this issuance.

On January 9, 2012, the Company issued 22,056,100 shares of common stock upon conversion of the $661,683 Convertible Note Payable. This issuance of common stock resulted in a change in control of the Company.

On January 12, 2012, the Company issued 9,000,000 shares of common stock upon conversion of a portion of the $517,673 Convertible Note Payable in the amount of $270,000.

On October 15, 2012, the Company issued 3,000,000 shares of common stock upon conversion of a portion of the $517,673 Convertible Note Payable in the amount of $90,000.

On October 30, 2012, the Company agreed to issue 41,667 shares of common stock for the acquisition of Global Cell Buyers, LLC. The shares have not been issued as of the filing of this report.

The Company has imputed interest on advances in the amount of $40,077 for the year ended December 31, 2012.  The imputed interest was recorded as an increase in additional paid-in capital.